• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

矽肺患者感染的不良结局

An Unfavorable Outcome of Infection in Patient with Silicosis.

作者信息

Łyżwa Ewa, Siemion-Szcześniak Izabela, Sobiecka Małgorzata, Lewandowska Katarzyna, Zimna Katarzyna, Bartosiewicz Małgorzata, Jakubowska Lilia, Augustynowicz-Kopeć Ewa, Tomkowski Witold

机构信息

1st Department of Lung Diseases, National Research Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland.

Department of Radiology, National Research Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland.

出版信息

Diagnostics (Basel). 2022 Jul 29;12(8):1826. doi: 10.3390/diagnostics12081826.

DOI:10.3390/diagnostics12081826
PMID:36010177
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9406696/
Abstract

is a slow-growing, nontuberculous mycobacterium (NTM) belonging to the (). It was identified as a unique species in 2004. Since 2013 it has been reported as a cause of disseminated infection in patients after cardiac surgeries. Only a few cases associated with underlying lung diseases have been noted. infection is characterized by ambiguous symptoms. There is no treatment with proven effectiveness, and it has a poor prognosis. Silicosis is a disease that can predispose to mycobacterial infection. Silica damages pulmonary macrophages, inhibiting their ability to kill mycobacteria. We present a case of infection in a patient with silicosis and without other comorbidities. To our knowledge, it is the first case of silicosis associated with disease. A 45-year-old man presented with a persistent low-grade fever. Based on the clinical and radiological picture, positive cultures, and histological examination, the nontuberculous mycobacterial disease was diagnosed. First, multidrug therapy according to the treatment guidelines for was implemented, then antibiotics were administrated, based on drug sensitivity. Despite the treatment, eradication was not achieved and the patient died. The analysis of infection cases could contribute to developing recommendations and thus improve the prognosis.

摘要

是一种生长缓慢的非结核分枝杆菌(NTM),属于()。它于2004年被鉴定为一个独特的物种。自2013年以来,它被报道为心脏手术后患者播散性感染的一个病因。仅发现少数与潜在肺部疾病相关的病例。感染的特征是症状不明确。没有经证实有效的治疗方法,且预后较差。矽肺是一种易引发分枝杆菌感染的疾病。二氧化硅会损害肺巨噬细胞,抑制其杀灭分枝杆菌的能力。我们报告一例矽肺且无其他合并症患者的感染病例。据我们所知,这是首例与疾病相关的矽肺病例。一名45岁男性出现持续低热。根据临床和影像学表现、阳性培养结果以及组织学检查,诊断为非结核分枝杆菌病。首先,根据的治疗指南实施多药治疗,然后根据药敏结果给予抗生素。尽管进行了治疗,但未实现根除,患者死亡。对感染病例的分析有助于制定建议,从而改善预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3769/9406696/7432a88a1ec6/diagnostics-12-01826-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3769/9406696/7432a88a1ec6/diagnostics-12-01826-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3769/9406696/7432a88a1ec6/diagnostics-12-01826-g006.jpg

相似文献

1
An Unfavorable Outcome of Infection in Patient with Silicosis.矽肺患者感染的不良结局
Diagnostics (Basel). 2022 Jul 29;12(8):1826. doi: 10.3390/diagnostics12081826.
2
Disseminated Mycobacterium chimaera infection in a patient with adult-onset immunodeficiency syndrome: case report.成人获得性免疫缺陷综合征患者播散性奇美拉分枝杆菌感染:病例报告。
BMC Infect Dis. 2022 Aug 1;22(1):665. doi: 10.1186/s12879-022-07656-0.
3
as an Underestimated Cause of NTM Lung Diseases in Patients Hospitalized in Pulmonary Wards.作为住院于肺病病房的 NTM 肺病患者的被低估病因。
Pol J Microbiol. 2021 Sep;70(3):315-320. doi: 10.33073/pjm-2021-028. Epub 2021 Sep 17.
4
Evaluation of a Novel MALDI Biotyper Algorithm to Distinguish From .评估一种用于区分……的新型基质辅助激光解吸电离生物分型算法。 (你提供的原文不完整,这里只能根据现有内容翻译,完整准确的翻译需补充完整原文)
Front Microbiol. 2018 Dec 18;9:3140. doi: 10.3389/fmicb.2018.03140. eCollection 2018.
5
Nationwide analysis of Mycobacterium chimaera and Mycobacterium intracellulare isolates: Frequency, clinical importance, and molecular and phenotypic resistance profiles.全国范围内对奇美拉分枝杆菌和胞内分枝杆菌分离株的分析:频率、临床重要性以及分子和表型耐药谱。
Infect Genet Evol. 2020 Aug;82:104311. doi: 10.1016/j.meegid.2020.104311. Epub 2020 Apr 2.
6
Clinical features and treatment outcomes of Mycobacterium chimaera lung disease and antimicrobial susceptibility of the mycobacterial isolates.奇曼分枝杆菌肺病的临床特征和治疗结果及分枝杆菌分离株的药敏情况。
J Infect. 2020 Apr;80(4):437-443. doi: 10.1016/j.jinf.2020.01.005. Epub 2020 Jan 17.
7
Comparison of methods available for identification of Mycobacterium chimaera.比较可用于鉴定耻垢分枝杆菌的方法。
Clin Microbiol Infect. 2018 Apr;24(4):409-413. doi: 10.1016/j.cmi.2017.07.031. Epub 2017 Aug 4.
8
Clinical implications of Mycobacterium chimaera detection in thermoregulatory devices used for extracorporeal membrane oxygenation (ECMO), Germany, 2015 to 2016.2015年至2016年德国体外膜肺氧合(ECMO)所用温度调节设备中检测到的奇美拉分枝杆菌的临床意义
Euro Surveill. 2016 Nov 17;21(46). doi: 10.2807/1560-7917.ES.2016.21.46.30398.
9
Absence of Mycobacterium intracellulare and presence of Mycobacterium chimaera in household water and biofilm samples of patients in the United States with Mycobacterium avium complex respiratory disease.在美国分枝杆菌复合群呼吸道疾病患者的家庭用水和生物膜样本中未检出胞内分枝杆菌,而检出了奇美拉分枝杆菌。
J Clin Microbiol. 2013 Jun;51(6):1747-52. doi: 10.1128/JCM.00186-13. Epub 2013 Mar 27.
10
Antimicrobial Susceptibility of Clinical and Environmental Mycobacterium chimaera Isolates.临床和环境分枝杆菌嵌合体分离株的抗菌药敏性。
Antimicrob Agents Chemother. 2019 Aug 23;63(9). doi: 10.1128/AAC.00755-19. Print 2019 Sep.

引用本文的文献

1
The State-of-the-Art of Infections and the Causal Link with Health Settings: A Systematic Review.感染的最新情况及其与健康环境的因果关系:一项系统综述。
Healthcare (Basel). 2024 Sep 6;12(17):1788. doi: 10.3390/healthcare12171788.

本文引用的文献

1
as an Underestimated Cause of NTM Lung Diseases in Patients Hospitalized in Pulmonary Wards.作为住院于肺病病房的 NTM 肺病患者的被低估病因。
Pol J Microbiol. 2021 Sep;70(3):315-320. doi: 10.33073/pjm-2021-028. Epub 2021 Sep 17.
2
Disseminated Infection.播散性感染
J Med Cases. 2020 Feb;11(2):35-36. doi: 10.14740/jmc3420. Epub 2020 Feb 28.
3
A novel pathogen with potential risk to cardiac surgical patients.一种可能对心脏外科患者造成风险的新型病原体。
Natl Med J India. 2020 Sep-Oct;33(5):284-287. doi: 10.4103/0970-258X.317473.
4
Mycobacterium chimaera: a report of 2 new cases and literature review.棘球白素菌:2 例新病例报告及文献复习。
Int J Legal Med. 2021 Nov;135(6):2667-2679. doi: 10.1007/s00414-021-02630-y. Epub 2021 Jun 29.
5
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.非结核分枝杆菌肺病治疗:美国胸科学会/欧洲呼吸学会/欧洲临床微生物学和传染病学会/美国感染病学会临床实践指南。
Clin Infect Dis. 2020 Aug 14;71(4):905-913. doi: 10.1093/cid/ciaa1125.
6
Mycobacterium chimaera infections: An update.棘球白素虫感染:最新进展。
J Infect Chemother. 2020 Mar;26(3):199-205. doi: 10.1016/j.jiac.2019.11.004. Epub 2019 Dec 13.
7
Antimicrobial Susceptibility of Clinical and Environmental Mycobacterium chimaera Isolates.临床和环境分枝杆菌嵌合体分离株的抗菌药敏性。
Antimicrob Agents Chemother. 2019 Aug 23;63(9). doi: 10.1128/AAC.00755-19. Print 2019 Sep.
8
Mycobacterium chimaera infection masquerading as a lung mass in a healthcare worker.一名医护人员身上出现伪装成肺部肿块的分枝杆菌感染。
IDCases. 2019 Mar 26;15:e00526. doi: 10.1016/j.idcr.2019.e00526. eCollection 2019.
9
Mycobacterium Chimaera Mimicking Sarcoidosis.酷似结节病的奇美拉分枝杆菌
Methodist Debakey Cardiovasc J. 2018 Oct-Dec;14(4):301-302. doi: 10.14797/mdcj-14-4-301.
10
Nontuberculous mycobacteria strains isolated from patients between 2013 and 2017 in Poland. Our data with respect to the global trends.2013年至2017年期间从波兰患者中分离出的非结核分枝杆菌菌株。我们关于全球趋势的数据。
Adv Respir Med. 2018 Dec 30;86(6):ARM.a2018.0047. doi: 10.5603/ARM.a2018.0047.